Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Diagnosis of brainstem involvement in NK/T cell lymphoma.

So JC, Chan KH, Pang AW, Chan JK, Kwong YL.

Ann Hematol. 2014 Aug;93(8):1433-4. doi: 10.1007/s00277-013-1971-2. Epub 2013 Nov 29. No abstract available.

PMID:
24292537
[PubMed - indexed for MEDLINE]
2.

Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.

Hildyard C, Sheikh S, Eyre T, Collins G.

Br J Haematol. 2013 Dec;163(5):550. doi: 10.1111/bjh.12553. Epub 2013 Sep 4. No abstract available.

PMID:
24033120
[PubMed - indexed for MEDLINE]
3.

Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.

Inoue D, Nagai Y, Takiuchi Y, Nagano S, Arima H, Kimura T, Shimoji S, Mori M, Togami K, Tabata S, Yanagita S, Matsushita A, Nagai K, Maruoka H, Imai Y, Suzuki R, Takahashi T.

Leuk Lymphoma. 2010 Apr;51(4):720-3. doi: 10.3109/10428191003682742. No abstract available.

PMID:
20233057
[PubMed - indexed for MEDLINE]
4.

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.

Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, Suzumiya J, Okamura T, Nakamura S, Kawa K, Oshimi K.

Cancer Sci. 2008 May;99(5):1016-20. doi: 10.1111/j.1349-7006.2008.00768.x. Epub 2008 Feb 19.

PMID:
18294294
[PubMed - indexed for MEDLINE]
5.

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, Devidas A, Petit B, de Leval L, Gaulard P, Feuillard J, Bordessoule D, Hermine O; GELA and GOELAMS Intergroup.

Blood. 2011 Feb 10;117(6):1834-9. doi: 10.1182/blood-2010-09-307454. Epub 2010 Dec 1.

PMID:
21123825
[PubMed - indexed for MEDLINE]
Free Article
6.

Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.

Suzuki R.

Int J Hematol. 2010 Dec;92(5):697-701. doi: 10.1007/s12185-010-0726-2. Epub 2010 Dec 1. Review.

PMID:
21116747
[PubMed - indexed for MEDLINE]
7.

Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.

Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R.

Clin Cancer Res. 2012 Aug 1;18(15):4183-90. Epub 2012 Jun 6.

PMID:
22675173
[PubMed - indexed for MEDLINE]
Free Article
8.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.

J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2.

PMID:
19884539
[PubMed - indexed for MEDLINE]
Free Article
9.

Successful treatment of secondary NK/T-cell lymphoma of the testis.

Kobayashi T, Hangaishi A, Yamamoto G, Shinohara A, Morikawa T, Takazawa Y, Ota S, Imai Y, Nakamura F, Kurokawa M.

Ann Hematol. 2013 Jul;92(7):997-8. doi: 10.1007/s00277-012-1657-1. Epub 2012 Dec 28. No abstract available.

PMID:
23271214
[PubMed - indexed for MEDLINE]
10.

Current and future management of NK/T-cell lymphoma based on clinical trials.

Yamaguchi M.

Int J Hematol. 2012 Nov;96(5):562-71. doi: 10.1007/s12185-012-1189-4. Epub 2012 Oct 17. Review.

PMID:
23073619
[PubMed - indexed for MEDLINE]
11.

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R.

J Clin Oncol. 2011 Nov 20;29(33):4410-6. doi: 10.1200/JCO.2011.35.6287. Epub 2011 Oct 11.

PMID:
21990393
[PubMed - indexed for MEDLINE]
Free Article
12.

Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance.

Kwong YL, Pang AW, Leung AY, Chim CS, Tse E.

Leukemia. 2014 Apr;28(4):865-70. doi: 10.1038/leu.2013.212. Epub 2013 Jul 11.

PMID:
23842425
[PubMed - indexed for MEDLINE]
13.

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.

Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AY, Chim CS.

Blood. 2012 Oct 11;120(15):2973-80. doi: 10.1182/blood-2012-05-431460. Epub 2012 Aug 23.

PMID:
22919026
[PubMed - indexed for MEDLINE]
Free Article
14.

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.

Kim BS, Kim DW, Im SA, Kim CW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK.

Ann Oncol. 2009 Jan;20(1):121-8. doi: 10.1093/annonc/mdn551. Epub 2008 Aug 5.

PMID:
18684695
[PubMed - indexed for MEDLINE]
Free Article
15.

[Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].

Monma F, Ueno S, Yamaguchi M, Tawara I, Miyazaki K, Nishii K, Nakase K, Katayama N.

Rinsho Ketsueki. 2009 Jan;50(1):44-8. Japanese.

PMID:
19225229
[PubMed - indexed for MEDLINE]
16.

[Successful treatment with high-dose methotrexate/cytarabine regimen in a patient in SMILE regimen-resistant extranodal natural killer/T-cell lymphoma].

Saburi M, Itani K, Nagamatsu K, Miyazaki Y, Otsuka E, Urabe S, Saburi Y.

Rinsho Ketsueki. 2014 Jan;55(1):120-4. Japanese.

PMID:
24492044
[PubMed - indexed for MEDLINE]
17.

Nasal extranodal peripheral NK/T-cell lymphoma treated by the protocol NK/T-cell high-dose-methotrexate L-asparaginase dexamethasone.

Bekadja MA, Benredouane H, Audouin J, Mansouri D, Mehadji H, Brahimi M, Arabi A, Osmani S, Entasoltane B.

Hematol Oncol Stem Cell Ther. 2011;4(1):49-50. No abstract available.

PMID:
21460609
[PubMed - indexed for MEDLINE]
Free Article
18.

Extranodal nasal NK/T-cell lymphoma with dissemination to the central nervous system: a case report.

Romero-Guadarrama MB, Aguilar-Martínez E.

Acta Cytol. 2010 Sep-Oct;54(5 Suppl):993-7.

PMID:
21053585
[PubMed - indexed for MEDLINE]
19.

Efficacy of a pegaspargase-based regimen in the treatment of newly-diagnosed extranodal natural killer/T-cell lymphoma.

Li L, Zhang C, Zhang L, Li X, Wu JJ, Sun ZC, Fu XR, Wang XH, Chang Y, Wang R, Qiu YJ, Zhang MZ.

Neoplasma. 2014;61(2):225-32. doi: 10.4149/neo_2014_029.

PMID:
24299319
[PubMed - indexed for MEDLINE]
20.

Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.

Wills AJ, O'Connor S, McMillan A.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):484-5. doi: 10.1136/jnnp.2007.133694. No abstract available.

PMID:
18344403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk